Chongqing Dingrun Medical Device Co., Ltd.

Chongqing Dingrun Medical Device Co., Ltd. (abbreviated as Chongqing Dingrun) is an innovative national high-tech enterprise dedicated to the field of in vitro diagnostics, integrating research and development, production, sales, and service. Dingrun has always focused on technological research and development, adhering to a craftsmanship-oriented approach.
"Guided by market demand, driven by R&D transformation and technological innovation," the company has built a specialized and integrated in vitro diagnostics system R&D platform through proprietary technology. Among them, the reagent R&D platform includes a cell culture laboratory, antibody engineering laboratory, protein engineering laboratory, coagulation research laboratory, immunoassay laboratory, and molecular diagnostics laboratory; the instrument R&D platform has professional research laboratories for coagulation, luminescence, immunology, biochemistry, as well as ergonomics, fluidic chip design, and mechanical design. The company has established the "Chongqing Engineering Technology Research Center for Immunoassay and Coagulation Testing" and the "Chongqing Postdoctoral Scientific Research Workstation." It has applied for 27 national invention patents, of which 18 have been authorized. With a strong technical R&D team and a standardized achievement transformation team, Chongqing Dingrun has initially built modern first-class instrument and reagent production lines, forming an annual output value production capacity of five billion yuan.
Chongqing Dingrun has a leading advantage in the research and development of its core product, thromboelastography. It has launched the ***th generation product, the thromboelastograph, and a full series of supporting reagent products. Our products are sold to more than 30 provinces and cities nationwide. The second-generation magnetic levitation product has been developed and is about to be launched, which will bring leapfrog development to coagulation testing technology.